SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-076326
Filing Date
2008-04-07
Accepted
2008-04-07 16:32:01
Documents
3
Period of Report
2008-04-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17675
2 LETTER FROM BDO SEIDMAN, LLP TO THE SECURITIES AND EXCHANGE COMMISSION dex161.htm EX-16.1 3030
3 GRAPHIC g97920img001.jpg GRAPHIC 6361
  Complete submission text file 0001193125-08-076326.txt   31147
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 08743257
SIC: 2834 Pharmaceutical Preparations